Compared to patients on conventional DMARD therapy, patients treated with anti-TNF seem to have a higher risk of serious infections, of tuberculosis, of infections by herpes zoster, and also the risk of melanoma seems to be slightly increased [3]. The gene discussed is TNF; the disease is infection.